Hubert Schrezenmeier to Risk Factors
This is a "connection" page, showing publications Hubert Schrezenmeier has written about Risk Factors.
Connection Strength
0.011
-
First line treatment of aplastic anemia with thymoglobuline in Europe and Asia: Outcome of 955 patients treated 2001-2012. Am J Hematol. 2018 05; 93(5):643-648.
Score: 0.006
-
Increased age-associated mortality risk in HLA-mismatched hematopoietic stem cell transplantation. Haematologica. 2017 04; 102(4):796-803.
Score: 0.005